As COVID-19 cases rise, WHO asks countries to strengthen surveillance
New Delhi, Dec 24: The World Health Organisation (WHO) has urged countries in South-East Asia to strengthen surveillance in view of the increasing cases of respiratory diseases, including due to COVID-19 and its new sub-variant JN.1, and influenza.
The WHO also urged people to take protective measures.
"The COVID-19 virus continues to evolve, change, and circulate in all countries globally. While current evidence suggests the additional public health risk posed by JN.1 is low, we must continue to track the evolution of these viruses to tailor our response.
"For this, countries must strengthen surveillance and sequencing, and ensure sharing of data," said Dr Poonam Khetrapal Singh, regional director, WHO South-East Asia.
WHO has classified JN.1 as a variant of interest following its rapid global spread. In recent weeks, JN.1 was reported in multiple countries, and its prevalence has been rapidly increasing globally.
Considering the limited available evidence, the additional public health risk posed by JN.1 is currently evaluated as low at the global level, Singh said.
It is anticipated that this variant may cause an increase in COVID-19 cases amid surge of infections of other viral and bacterial infections, especially in countries entering the winter season.
"As people travel and gather for festivities during the holiday season, spending a lot of time together indoors where poor ventilation facilitates transmission of viruses that cause respiratory diseases, they must take protective measures and seek timely clinical care when unwell," said Dr Khetrapal Singh.
The regional director also emphasised on the importance of vaccination against COVID-19 and influenza, especially for people at high risk.
"All WHO-approved COVID-19 vaccines continue to protect against severe diseases and deaths from all variants including JN.1," she said.
In May, following sustained decline in the trajectory of COVID-19 cases, hospitalisations and deaths, and high levels of population immunity to SARS-CoV2, WHO declared that COVID-19 no longer constituted a public health emergency of international concern.
While considerable progress has been made in establishing and strengthening a global system to detect and rapidly assess risks posed by SARS-CoV2, testing and reporting of COVID-19 cases has decreased.
With COVID-19 continuing to circulate at high levels globally, countries must strengthen surveillance, sequencing, and reporting to effectively manage respiratory diseases and to protect people's health, the regional director said.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
KMC Mangaluru team led by Dr. Haroon files patent for absorbent pads for elderly women
Aims to address urinary incontinence in elderly women
_vb_78.jpeg)
Mangaluru: Kasturba Medical College (KMC) has filed a patent application for “Absorbent Pads” designed to address urinary incontinence among elderly women, a condition that remains largely underreported despite its widespread impact.
Urinary incontinence does not command urgency like a heart attack, nor does it evoke the same collective response as more visible illnesses. However, for those living with it, the burden is constant, intimate, and often isolating.
There is a gradual and often unspoken impact on daily life. It begins with hesitation, declining invitations, avoiding travel, and choosing silence over conversation. Over time, this can lead to withdrawal, where fear of embarrassment starts shaping everyday decisions. For many elderly women, dignity becomes tied to small, often invisible compromises, including limiting outings or adjusting routines.
What makes this condition particularly poignant is not just its prevalence, but its invisibility. It is endured, not expressed. Accepted, not addressed.
It is in this context that the recent innovation assumes importance. The team at KMC, which includes clinicians such as Dr Haroon Hussain, has approached the issue not merely from a technical standpoint but from the perspective of lived experience.
The proposed solution, biodegradable, antimicrobial absorbent pads with improved fluid control and reduced irritation, aims to go beyond basic functionality, addressing comfort, safety, and dignity.
The development also reflects the role of academic institutions in addressing everyday health challenges. When research focuses not only on major diseases but also on conditions that affect quality of life, it reinforces the broader purpose of healthcare.
However, experts note that innovation alone cannot fully address the issue. Urinary incontinence continues to be underreported, often dismissed as an inevitable consequence of ageing. Many women do not seek medical help, not due to a lack of solutions, but because of stigma and discomfort associated with discussing the condition.
This creates a paradox, a widespread issue that is often experienced in isolation.
Medical professionals emphasise that greater awareness and open conversations are essential. Families must learn to speak about such issues without embarrassment. Healthcare providers must create spaces where patients feel heard without judgment.
The significance of this innovation lies not only in its technical aspects but also in what it brings into focus, that even the most private discomforts deserve public attention.
The patent application was filed by a team comprising Dr. Haroon Hussain, Dr. Sameena, Dr. Ritu Raval of Manipal Institute of Technology, Syed Ayaan Hussain Rizvi, and Suzanne Riya Dsouza.
_vb_49.jpeg)
_vb_90.jpeg)